Hyperthermic Intra-Abdominal Chemotherapy with Gemcitabine as an Adjuvant Locoregional Treatment After Radical Surgery in Pancreatic Cancer

Hyperthermic Intra-Abdominal Chemotherapy with Gemcitabine as an Adjuvant Locoregional Treatment After Radical Surgery in Pancreatic Cancer

Review Data

§  Significance of the Study: This study, involving 5 patients, shows the beneficial role of hyperthermic intra-abdominal chemotherapy (HIPEC) by achieving a decrease in the tumor progression of pancreatic cancer, improving the survival of the patient, and decreasing the recurrence of the disease using locoregional treatment associated with radical surgery. A larger number of patients will be necessary, as well as a long-term evaluation to assess the possible increase in survival in this group of patients.

§  Fit with the Scope of the Journal: The manuscript perfectly fits with the scope of the journal Surgical Case Reports.

§  The discussion elaborates on the rationale behind the benefit of using locoregional treatment associated with radical surgery, together with the administration of HIPEC, in pancreatic cancer. It also adequately discusses the literature relevant to this study. The conclusions are consistent with the evidences presented in this article.

§  A couple of errors are given below:

o   Figure 2 is neither given nor mentioned in the text section of the manuscript. Also Figure 1A and 1B are not mentioned separately in the figure and are not cited in the text section of the article.

o   The 1st sentence of the 9th paragraph of the Discussion does not make sense. Hence, it should be rephrased.

Author Info

Corresponding Author
Esther Pilar García Santos
Servicio de Cirugía General y del Aparato Digestivo, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain

Article Info

Article Type
Research Article
Publication history
Received: Thu 25, Jun 2020
Accepted: Wed 15, Jul 2020
Published: Tue 28, Jul 2020
Copyright
© 2023 Esther Pilar García Santos. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Hosting by Science Repository.
DOI: 10.31487/j.SCR.2020.07.16